Paloma Partners’s Kite Pharma, Inc. KITE Stock Holding History
Bought
Maintained
Sold
Paloma Partners's KITE Position: Q4 2017 in Review
Paloma Partners sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 23,199 shares — an estimated $4.17M sold.
Paloma Partners first reported a position in KITE in Q2 2017 and held it in 2 quarters. The position peaked at $4.17M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.
- Paloma Partners reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
- Paloma Partners sold 23,199 Kite Pharma, Inc. shares in Q4 2017, an estimated $4.17M.
- Paloma Partners first reported a position in Kite Pharma, Inc. in Q2 2017 and held it in 2 quarters.
- Paloma Partners's Kite Pharma, Inc. position peaked at $4.17M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.
Based on Paloma Partners's 13F filing for Q4 2017, filed 14 Feb 2018.